The impact of maternal anti-retroviral therapy on cytokine profile in the uninfected neonates

被引:10
|
作者
Kasahara, Taissa M. [1 ]
Hygino, Joana [1 ]
Blanco, Bernardo [1 ]
Xavier, Luciana [1 ]
Araujo-Lima, Carlos Fernando [1 ]
Guillermo, Landi V. C. [1 ]
Bittencourt, Vera Carolina B. [1 ]
Guimaraes, Vander [2 ]
Andrade, Arnaldo F. B. [3 ]
Bento, Cleonice A. M. [1 ]
机构
[1] Univ Fed Rio de Janeiro, Dept Microbiol & Parasitol, BR-20261040 Rio De Janeiro, Brazil
[2] Inst Oswaldo Cruz, Fernandes Figueira Inst, BR-20001 Rio De Janeiro, Brazil
[3] Univ Estado Rio De Janeiro, Dept Microbiol Parasitol & Immunol, Rio De Janeiro, Brazil
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REGULATORY T-CELLS; IMMUNE-RESPONSES; NATURAL-KILLER; TRANSMISSION; PREGNANCY; RISK; ABORTION; CHILDREN; ROLES;
D O I
10.1016/j.humimm.2013.06.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The number of HIV-infected young women has been increasing since the beginning of the AIDS epidemic. The objective of the present study was to investigate the impact of anti-retroviral treatment (ART) of HIV1-infected pregnant women (PW) on cytokine profile of uninfected neonates. Our results demonstrated that higher levels of IL-1 beta and TNF-alpha associated with lower IL-10 production were detected in the plasma obtained from neonates born from ART-treated PW. Furthermore, the production of TNF-alpha and IFN-gamma was also significantly higher in polyclonally-activated T cells from those neonates. This elevated pro-inflammatory pattern detected by these activated-T cells was not associated to HIV-1 antigens sensitization. Finally, ART-exposed neonates showed to be born with lower weight, and it was inversely correlated with maternal peripheral TNF-a level. In summary, the data presented here suggest a significant disturbance in cytokine network of HIV-1-uninfected neonates exposed to potent anti-retroviral schemes during pregnancy. (C) 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1051 / 1056
页数:6
相关论文
共 50 条
  • [31] Clinical and economic impact of new anti-retroviral therapies
    Guillén, SM
    Elías, MJP
    REVISTA CLINICA ESPANOLA, 1999, 199 (02): : 53 - 54
  • [32] Assessing the impact of adherence to anti-retroviral therapy on treatment failure and resistance evolution in HIV
    Cadosch, Dominique
    Bonhoeffer, Sebastian
    Kouyos, Roger
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2012, 9 (74) : 2309 - 2320
  • [33] The impact of highly active combination anti-retroviral therapy in Glasgow 1994-98
    Gourlay, Y
    Kennedy, DH
    Pithie, AD
    Fox, R
    AIDS, 1998, 12 : S46 - S46
  • [34] HIV-1 rebound after anti-retroviral therapy
    Ho, DD
    Zhang, LQ
    NATURE MEDICINE, 2000, 6 (07) : 736 - 737
  • [35] HIV-1 rebound after anti-retroviral therapy
    David D. Ho
    Linqi Zhang
    Nature Medicine, 2000, 6 : 736 - 737
  • [36] Protease inhibitors in anti-retroviral therapy: past, present and future
    Orkin, Chloe
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S14 - S14
  • [37] Accession of children and adolescents to anti-retroviral therapy: strategies for care
    Cardim, Mariana Gomes
    Norte, Monique de Sales
    Nunes Moreira, Martha Cristina
    REVISTA DE PESQUISA-CUIDADO E FUNDAMENTAL ONLINE, 2013, 5 (05): : 82 - 94
  • [38] Tooth wear in patients treated with HIV anti-retroviral therapy
    Sehgal, Harjit Singh
    Kohli, Richie
    Pham, Edward
    Beck, Grace E.
    Anderson, Jay R.
    BMC ORAL HEALTH, 2019, 19 (1)
  • [39] Cytomegalovirus retinitis in the highly active anti-retroviral therapy era
    Ude, Ifeoma N.
    Yeh, Steven
    Shantha, Jessica G.
    ANNALS OF EYE SCIENCE, 2022, 7
  • [40] Cost impact of an HIV MDT for managing anti-retroviral switch
    Dave, F.
    Sayers, I.
    Niazi, F.
    Torkington, A.
    Wilkins, E.
    Ajdukiewicz, K.
    HIV MEDICINE, 2016, 17 : 12 - 12